Pasternak Andy's Form 4 filing
Horizon Therapeutics Public Ltd Co (HZNP) · filed Jul 29, 2022
- Accession no.
- 0001209191-22-043548
- Filed
- Jul 29, 2022
- Trade date
- Jul 29, 2022
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $400.5K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Pasternak AndyCIK 0001792746 | Officer (EVP and Chief Business Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 29, 2022 | Ordinary Shares | SSaleDisposed | −4,207 | $82.44 | −$346,825.08 | 34,690 | Direct | |
| Jul 29, 2022 | Ordinary Shares | SSaleDisposed | −643 | $83.45 | −$53,658.35 | 34,047 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.